Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells

Medical Science Monitor

Volumn 18, Issue 1, 2012, Pages

  Szliszka, Ewelina ^a   Czuba, Zenon P ^a   Kawczyk Krupka, Aleksandra ^a   Sieron Stoltny, Karolina ^a   Sieron, Aleksander ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Bladder cancer; PDT; TCC; TRAIL

Indexed keywords

CHLORIN E6 POLYVINYLPYRROLIDONE; LIPOCORTIN 5; PHOTOSENSITIZING AGENT; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; TUMOR RESISTANCE;

EID: 84855280821     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882203     Document Type: Article

References (48)

1. Stein JP, Grossfeld GD, Ginsberg DA et al: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol, 1998; 160: 645-59
2. Colombel M, Soloway M, Akaza H et al: Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol, 2008; 7: 618-26
3. Grasso M: Bladder cancer: a major public health issue. Eur Urol, 2008; 7: 510-15
4. French AJ, Datta SN, Allman R, Matthews PN: Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cell-line model. BJU International, 2004; 93: 156-61
5. O'Donnell MA: Advances in the management of superficial bladder cancer. Semin Oncol, 2007; 34: 85-97
6. Weidelich R, Beyer W, Knuchel R et al: Whole bladder photodynamic therapy with 5-aminolevulic acid using a white light source. Urology, 2003; 61: 332-37
7. D'Hallevin MA, Baert L, Marijnissen JP, Star WM: Whole bladder wall photodynamic therapy with in situ light dosimetry from carcinoma in situ of the bladder. J Urol, 1992; 148: 1152-55
8. Pass HI: Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst, 1993; 85: 443-56
9. Dolmans DE, Fukumura D, Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer, 2003; 3: 380-87
10. Xu CS, Leung AW: Photodynamic effects of pyropheophorbidea methyl ester in nasopharyngeal carcinoma cells. Med Sci Monit, 2006; 12(8): BR257-62
11. Chin WW, Heng PW, Thong PS et al: Fluorescence imaging and phototoxicity effects of a new formulation of chlorin e6-polyvinylpyrrolidone. J Photochem Photobiol B, 2006; 84: 103-10
12. Podbielska H, Ulatowska-Jarza A, Muller G et al: Silica sol-gel matrix doped with Photolon molecules for sensing and medical therapy purposes. Biomol Eng, 2007; 24: 425-33
13. Chin WW, Heng PW, Thong PS et al: Improved formulation of photosensitizer chlorin e6-polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Eur J Pharm Biopharm, 2008; 69: 1083-93
14. Lee LS, Thong PS, Olivo M et al: Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy - a potential bladder sparing option for high risk non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther, 2010; 7: 213-20
15. Almeida RD, Manadas BJ, Carvalho AP, Duarte CB: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta, 2004; 1704: 59-86
16. Firczuk M, Nowis D, Gołab J: PDT-induced inflammatory and host responses. Photochem Photobiol Sci, 2011; 10: 653-63
17. Kawczyk-Krupka A, Czuba ZP, Szliszka E et al: The role of photosensitized macrophages cells in photodynamic therapy. Oncol Rep, 2011; 26: 275-80
18. Xia C, Wang Y, Chen W et al: New hydrophilic/lipophilic tetra-a-(4- carboxyphenoxy) phthalocyanine zinc-mediated photodynamic therapy inhibits the proliferation of human hepatocellular carcinoma Bel- 7402 cells by triggering apoptosis and arresting cell cycle. Molecules, 2011; 16: 1389-401
19. Buytaert E, Dewaele M, Agostinis P: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochem Biophys Acta, 2007; 1776: 86-107
20. Yoo JO, Lim YC, Kim YM, Ha KS: Differential cytotoxic responses to low- and high-dose photodynamic therapy in human gastric and blad- der cancer cells. J Cell Biochem, 2011; 112: 3061-71
21. Kruyt F: TRAIL and cancer therapy. Cancer Lett, 2008; 263: 14-25
22. Holoch PA, Griffith TS: TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol, 2009; 625: 63-72
23. Duiker EW, Mom CH, Jong S et al: The clinical trail of TRAIL. Eur J Cancer, 2006; 42: 2233-40
24. Lee JY, Huerta-Yepez S, Vega M et al: The NO TRAIL to YES TRAIL in cancer therapy (review). Int J Oncol, 2007; 31: 685-91
25. Russo M, Mupo A, Spagnuolo C, Russo GL: Exploring death receptor pathways as selective targets in cancer therapy. Biochem Pharmacol, 2010; 80: 674-82
26. Zhang L, Fang B: Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther, 2005; 12: 228-27
27. Thorburn A, Behbakht K, Ford H: TRAIL-receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist Updat, 2008; 11: 17-24
28. Szliszka E, Czuba ZP, Mazur B et al: TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells. Folia Histochem Cytobiol, 2009; 47: 579-85
29. Mizutani Y, Nakao M, Ogawa O et al: Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin. J Urol, 2001; 165: 263-70
30. Shankar S, Srivastava RK: Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist Updat, 2004; 7; 139-56
31. Baierlein SA, Distel L, Sieber L: Combined effect of tumor necrosis factor and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells. Strahlenther Oncol, 2006; 182: 467-72
32. Szliszka E, Majcher A, Domino M et al: Cytotoxic activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) against bladder cancer cells after using chemotherapeutic drugs. Urol Pol, 2007; 60: 138-42
33. Szliszka E, Gebka J, Bronikowska J, Krol W: Dietary flavones enhance the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on bladder cancer cells. CEJ Urol, 2010; 63: 138-43
34. Szliszka E: Cytotoxic activity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) against bladder cancer cells after photodynamic therapy pretreatment. Doctoral Thesis, 2005; SUM Katowice
35. Szliszka E, Czuba ZP, Domino M et al: Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules, 2009; 14: 738-54
36. Bronikowska J, Szliszka E, Czuba ZP et al: The combination of TRAIL and isoflavones enhance apoptosis in cancer cells. Molecules, 2010; 15: 2000-15
37. Gruber BM, Bubko I, Krzyszton-Russjan J, Anuszewska EL: Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms. Med Sci Monit, 2010; 16(1): BR45-51
38. Gambarini G, Plotino G, Grande NM et al: In vitro evaluation of the cytotoxicity of FotoSanTM light-activated disinfection on human fibroblasts. Med Sci Monit, 2011; 17(3): 21-25
39. Kulahava TA, Semenkova GN, Kvacheva ZB et al: Modification of redox processes in astroglial cells induced by microbial and viral infections. Med Sci Monit, 2010; 16(6): 11-17
40. Jia L, Huang XL, Zhao Y et al: Vitamin E succinate (VES) inhibits cell growth and induces apoptosis by mitochondrial-derived ROS in SGC-7901 cells. Med Sci Monit, 2010; 16(5): 131-39
41. Szliszka E, Czuba ZP, Jernas K, Krol W: Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Mol Sci, 2008; 9: 56-64
42. Szliszka E, Czuba ZP, Mazur B et al: Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci, 2010; 11: 1-13
43. Szliszka E, Czuba ZP, Mazur B et al: Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules, 2010; 15: 5336-53
44. Szliszka E, Czuba ZP, Bronikowska J et al: Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells. Evid Based Complement Alternat Med, 2011; 2011: 1-11
45. Szliszka E, Zydowicz G, Janoszka B et al: Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol, 2011; 38: 941-53
46. Szliszka E, Czuba ZP, Sedek L et al: Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Rep, 2011; 63: 139-48
47. Chin WW, Thong PS, Bhuvaneswari R et al: In-vivo optical detection of cancer using chlorin e6-polyvinylpyrrolidone induced fluorescence imaging and spectroscopy. BMC Med Imaging, 2009; 9: 1-13
48. Granville DJ, Jiang H, McManus BM et al: Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. Int Immunopharmacol, 2001; 1: 1831-40